Isolation and clinical significance of Pseudallescheria and Scedosporium species

Medical Mycology

Volumn 47, Issue 4, 2009, Pages 415-421

  Horré, Regine ^a,b   Marklein, G ^a  

^a UNIVERSITY OF BONN   (Germany)

^b FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES   (Germany)

Author keywords

Clinical significance; Isolation techniques; Pseudallescheria; Scedosporium

Indexed keywords

GALACTOMANNAN;

ADOLESCENT; ADULT; ASCOMYCETES; BLOOD CULTURE; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CYSTIC FIBROSIS; FEMALE; FUNGAL COLONIZATION; FUNGAL STRAIN; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; HUMAN TISSUE; LUNG MYCOSIS; MALE; SCEDOSPORIUM; SEROLOGY; ARTICLE; DIAGNOSIS, MEASUREMENT AND ANALYSIS; GERMANY; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGY; MIDDLE AGED; MYCOSIS; PRESCHOOL CHILD; PREVALENCE;

PSEUDALLESCHERIA; SCEDOSPORIUM;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CLINICAL LABORATORY TECHNIQUES; FEMALE; GERMANY; HUMANS; MALE; MIDDLE AGED; MYCOSES; PREVALENCE; PSEUDALLESCHERIA; SCEDOSPORIUM; YOUNG ADULT;

EID: 67449102484     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780902801259     Document Type: Conference Paper

References (36)

1. Hoog GS de, Guarro J, Gené J, Figueras MJ (eds). Atlas of Clinical Fungi, 2nd edn. 2000. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands; Universitat Rovira i Virgili, Reus, Spain.
2. Gilgado F, Cano J, Gene J, Guarro J. Molecular phylogeny of the Pseudallescheria boydii species complex: Proposal of two new species. J Clin Microbiol 2005; 43: 4930-4942.
3. Gilgado F, Cano J, Gené J, Sutton DA, Guarro J. Molecular and phenotypic data supporting distinct species statuses for Scedosporium apiospermum and Pseudallescheria boydii and the proposed new species Scedosporium dehoogii. J Clin Microbiol 2008; 46 766-771.
4. Guarro J, Kantarcioglu AS, Horré R, et al. Scedosporium apiospermum: Changing clinical spectrum of a therapy-refractory opportunist. Med Mycol 2006; 44: 295-327.
5. Cortez KJ, Roilides E, Quiroz-Telles F, et al. Infections caused by Scedosporium spp. Clin Microbiol Rev 2008; 21: 157-197.
6. Ariewitsch AM, Stepaniszewa SG, Tiufilina OW. [A case of lung mycetoma caused by Monosporium apiospermum]. Mycopathologia 1968; 37: 171-178. [In German].
7. Kathuria SK, Rippon J. Non-Aspergillus aspergilloma. Am J Clin Pathol 1982; 78: 870-873.
8. Walsh TJ, Chanock SJ. Diagnosis of invasive fungal infections: Advances in nonculture systems. Curr Clin Trop Infect Dis 1998; 18: 101-153.
9. Lopez FA, Crowley RS, Wastila L, Valantine HA, Remington JS. Scedosporium apiospermum (Pseudallescheria boydii) infection in a heart transplant recipient: A case of mistaken identity. J Heart Lung Transplant 1998; 17: 321-324.
10. Gilgado F, Serena C, Cano J, Gene J, Guarro J. Antifungal susceptibilities of the species of the Pseudallescheria boydii complex. Antimicrob Agents Chemother 2006; 50: 4211-4213.
11. Cuenca-Estrella M, Alastruey-Izquierdo A, Alcazar-Fuoli L, et al. Activity in vitro of 35 double combinations of antifungal agents against Scedosporium apiospermum and Scedosporium prolificans Antimicrob Agents Chemother 2008; 52: 1136-1139.
12. Safdar A, Papadopoulos EB, Young JW. Breakthrough Scedosporium apiospermum (Pseudallescheria boydii) brain abscess during therapy for invasive pulmonary aspergillosis following high-risk allogeneic hematopoietic stem cell transplantation. Scedosporiasis and recent advances in antifungal therapy. Transpl Infect Dis 2002; 4: 212-217.
13. Goldberg SL, Geha DJ, Marshall WF, Inwards DJ, Haogland HC. Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole. Clin Infect Dis 1993; 16: 803-805.
14. Rüchel R. False-positive reaction of a Cryptococcus antigen test owing to Pseudallescheria mycosis. Mycoses 1994; 37 69.
15. Rodriguez-Tudela JL, Berenguer J, Guarro J, et al. Epidemiology and outcome of Scedosporium prolificans infection, a review of 162 cases. Med Mycol 2008; 46: 1-12. [Epub ahead of print].
16. Meletiadis J, Mouton JW, Meis JF, Verweij PE. Combination chemotherapy for the treatment of invasive infections by Scedosporium prolificans Clin Microbiol Infect 2000; 6: 336-337.
17. Troke P, Aguirrebengoa K, Arteaga C, et al. Treatment of scedosporiosis with voriconazole: Clinical experience with 107 patients. Antimicrob Agents Chemother 2008; 52: 1743-1750.
18. Mursch K, Trnovec S, Ratz H, et al. Successful treatment of multiple Pseudallescheria boydii brain abscesses and ventriculitis/ependymitis in a 2-year-old child after near-drowning. Childs Nerv Syst 2006; 22: 189-192.
19. Horré R, Feil E, Stangel AP, et al. [Scedosporiosis of the brain with fatal outcome after traumatisation of the foot. Case report.] Mycoses 2000; 43 (Suppl. 2): 33-36. [In German].
20. Tong SY, Peleg AY, Yoong J, et al. Breakthrough Scedosporium prolificans infection while receiving voriconazole prophylaxis in an allogeneic stem cell transplant recipient. Transpl Infect Dis 2007; 9: 241-243.
21. Horré R, Marklein G, Siekmeier R, Nidermajer S, Reiffert SM. Selective isolation of Pseudallescheria and Scedosporium species from respiratory tract specimens of cystic fibrosis patients. Respiration 2008; Oct 28. [Epub ahead of print].
22. Summerbell RC. The benomyl test as a fundamental diagnostic method for medical mycology. J Clin Microbiol 1993; 31: 572-577.
23. Rainer J, Kaltseis J, de Hoog GS, Summerbell RC. Efficacy of a selective isolation procedure for species of the Pseudallescheria boydii complex. Antonie Van Leeuwenhoek 2008; 93: 315-322.
24. Kauffmann-Lacroix C, Rodier MH, Jacquemin JL, et al. Detection of galactomannan for diagnosis of fungal rhinosinusitis. J Clin Microbiol 2001; 39: 4593-4594.
25. Dupont B, Improvisi L, Ronin O. Epidemiological and clinical aspects of infections due to Scedosporium and Pseudallescheria. J Mycol Med 1991; 1: 33-42. [In French].
26. Katragkou A, Dotis J, Kotsiou M, Tamiolaki M, Roilides E. Scedosporium apiospermum infection after near-drowning. Mycoses 2007; 50: 412-421.
27. Barbaric D, Shaw PJ. Scedosporium infection in immunocompromised patients: Successful use of liposomal amphotericin B and itraconazole. Med Pediatr Oncol 2001; 37: 122-125.
28. Davis JS, Wellman AM, Zajic JE. Hyphomycetes utilizing natural gas. Can J Microbiol 1973; 19: 81-85.
29. Travis LB, Roberts GD, Wilson WR. Clinical significance of Pseudallescheria boydii: A review of 10 years' experience. Mayo Clin Proc 1985; 60: 531-537.
30. Smith AG, Crain SM, Dejongh C, Thomas GM, Vigorito RD. Systemic pseudallescheriasis in a patient with acute myelocytic leukaemia. Mycopathologia 1985; 90: 85-89.
31. Rosen P, Adelson HT, Burleigh E. Bronchiectasis complicated by the presence of Monosporium apiospermum and Aspergillus fumigatus Am J Clin Pathol 1969; 52: 182-187.
32. Cimon B, Carrere J, Vinatier JF, et al. Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis. Eur J Clin Microbiol Infect Dis 2000; 19: 53-56.
33. Garcia E, Rodriguez V, Gartner S, Gené J. Isolation of Scedosporium prolificans in patients with cystic fibrosis. Enferm Infecc Microbiol Clin 1998; 16: 488-489.
34. Symoens F, Knoop C, Schrooyen M, et al. Disseminated Scedosporium apiospermum infection in a cystic fibrosis patient after double-lung transplantation. J Heart Lung Transplant 2006; 25 603-607.
35. Sahi H, Avery RK, Minai OA, et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007; 26: 350-356.
36. Shah SS, Karnak D, Budev M, Avery RK, Mehta AC. Endobronchial Pseudallescheria boydii in lung transplant patient with cystic fibrosis: Bronchoscopic images. J Bronchol 2007; 14: 48-50.